bioMérieux S.A. (BMXXY)
OTCMKTS · Delayed Price · Currency is USD
14.62
+0.79 (5.71%)
At close: Aug 5, 2025
bioMérieux Market Cap
bioMérieux has a market cap or net worth of $15.78 billion as of September 19, 2025. Its market cap has increased by 10.92% in one year.
Market Cap
15.78B
Enterprise Value
15.93B
Revenue
4.84B
Ranking
n/a
PE Ratio
35.56
Stock Price
$14.62
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.46B to 15.78B, an increase of 977.97%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 15.78B | 24.80% |
| Dec 31, 2024 | 12.64B | -3.73% |
| Dec 29, 2023 | 13.14B | 6.03% |
| Dec 30, 2022 | 12.39B | -26.30% |
| Dec 31, 2021 | 16.81B | 0.64% |
| Dec 31, 2020 | 16.70B | 58.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 719.18M |
| Elite Pharmaceuticals | 697.08M |
| Glass House Brands | 575.59M |
| Northwest Biotherapeutics | 378.39M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 352.05M |
| American Oncology Network | 340.34M |